advertisement
Pharmaceuticals (Basel, Switzerland) 69
Showing records 1 to 25 | Display all abstracts in Pharmaceuticals (Basel, Switzerland)123749 What's New in Ocular Drug Delivery: Advances in Suprachoroidal Injection since 2023
Wu KY
Pharmaceuticals (Basel, Switzerland) 2024; 17:
123417 Evidence of Cannabidiol Effectiveness Associated or Not with Tetrahydrocannabinol in Topical Administration: A Scope Review
Fava ALM
Pharmaceuticals (Basel, Switzerland) 2024; 17:
120317 Review: Neuroprotective Nanocarriers in Glaucoma
Pei K
Pharmaceuticals (Basel, Switzerland) 2024; 17:
120221 The Identification of New Pharmacological Targets for the Treatment of Glaucoma: A Network Pharmacology Approach
Giuffrida E
Pharmaceuticals (Basel, Switzerland) 2024; 17:
123853 Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema-A Swiss Cohort Study
Turgut F
Pharmaceuticals (Basel, Switzerland) 2024; 17:
119829 Advances in Neuroprotection in Glaucoma: Pharmacological Strategies and Emerging Technologies
Wang LH
Pharmaceuticals (Basel, Switzerland) 2024; 17:
124868 Neuroprotective Actions of Hydrogen Sulfide-Releasing Compounds in Isolated Bovine Retinae
Bush L
Pharmaceuticals (Basel, Switzerland) 2024; 17:
120506 Drug Delivery Systems for Glaucoma: A Narrative Review
Fea AM
Pharmaceuticals (Basel, Switzerland) 2024; 17:
123865 Assessment of Brain-Derived Neurotrophic Factor on Retinal Structure and Visual Function in Rodent Models of Optic Nerve Crush
Taniguchi T
Pharmaceuticals (Basel, Switzerland) 2024; 17:
124383 Glutathione Modulates Hydrogen Sulfide Release and the Ocular Hypotensive Action of Diallyl Polysulfide Compounds
Mhatre S
Pharmaceuticals (Basel, Switzerland) 2024; 17:
123865 Assessment of Brain-Derived Neurotrophic Factor on Retinal Structure and Visual Function in Rodent Models of Optic Nerve Crush
Sharif NA
Pharmaceuticals (Basel, Switzerland) 2024; 17:
120506 Drug Delivery Systems for Glaucoma: A Narrative Review
Vallino V
Pharmaceuticals (Basel, Switzerland) 2024; 17:
119829 Advances in Neuroprotection in Glaucoma: Pharmacological Strategies and Emerging Technologies
Huang CH
Pharmaceuticals (Basel, Switzerland) 2024; 17:
123417 Evidence of Cannabidiol Effectiveness Associated or Not with Tetrahydrocannabinol in Topical Administration: A Scope Review
Souza CM
Pharmaceuticals (Basel, Switzerland) 2024; 17:
120221 The Identification of New Pharmacological Targets for the Treatment of Glaucoma: A Network Pharmacology Approach
Platania CBM
Pharmaceuticals (Basel, Switzerland) 2024; 17:
124383 Glutathione Modulates Hydrogen Sulfide Release and the Ocular Hypotensive Action of Diallyl Polysulfide Compounds
Anjali R
Pharmaceuticals (Basel, Switzerland) 2024; 17:
124868 Neuroprotective Actions of Hydrogen Sulfide-Releasing Compounds in Isolated Bovine Retinae
Robinson J
Pharmaceuticals (Basel, Switzerland) 2024; 17:
120317 Review: Neuroprotective Nanocarriers in Glaucoma
Georgi M
Pharmaceuticals (Basel, Switzerland) 2024; 17:
123853 Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema-A Swiss Cohort Study
Somfai GM
Pharmaceuticals (Basel, Switzerland) 2024; 17:
123749 What's New in Ocular Drug Delivery: Advances in Suprachoroidal Injection since 2023
Gao A
Pharmaceuticals (Basel, Switzerland) 2024; 17:
124868 Neuroprotective Actions of Hydrogen Sulfide-Releasing Compounds in Isolated Bovine Retinae
Okolie A
Pharmaceuticals (Basel, Switzerland) 2024; 17:
120317 Review: Neuroprotective Nanocarriers in Glaucoma
Hill D
Pharmaceuticals (Basel, Switzerland) 2024; 17:
124383 Glutathione Modulates Hydrogen Sulfide Release and the Ocular Hypotensive Action of Diallyl Polysulfide Compounds
Sahai P
Pharmaceuticals (Basel, Switzerland) 2024; 17:
123853 Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema-A Swiss Cohort Study
Tappeiner C
Pharmaceuticals (Basel, Switzerland) 2024; 17:
123749 What's New in Ocular Drug Delivery: Advances in Suprachoroidal Injection since 2023
Giunta M
Pharmaceuticals (Basel, Switzerland) 2024; 17:
